Astal Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	13.01	17.3	60.77	0.84	0.18
Loans & Lease Receivables	40.93	40.93	39.93	37.88	51.12
Other Receivables	1,563	276.64	158.15	31.87	-
Property, Plant & Equipment	644.6	114.44	6.9	0.06	0.14
Goodwill	2,032	-	-	-	-
Other Current Assets	183.27	14.85	37.79	28.43	0.79
Long-Term Deferred Tax Assets	-	-	-	0.01	0.07
Other Long-Term Assets	29.43	21.65	52.03	-	-
Total Assets	5,182	633.41	366.13	99.08	52.29
Accounts Payable	1,238	107.75	115.15	37.93	-
Accrued Expenses	-	0.41	0.55	0.42	-
Current Portion of Long-Term Debt	304.42	128.12	0.55	-	-
Current Portion of Leases	1.62	-	-	-	-
Long-Term Debt	186.42	4.56	2.57	-	-
Long-Term Leases	6.48	-	-	-	-
Current Income Taxes Payable	-	31.31	3.82	-	-
Other Current Liabilities	98.78	0.12	10.03	8.96	0.69
Long-Term Deferred Tax Liabilities	8.62	1.19	0.07	-	-
Other Long-Term Liabilities	0	-	-	-	0
Total Liabilities	1,844	273.46	132.74	47.31	0.69
Common Stock	422.31	98.3	98.3	39.74	39.74
Additional Paid-In Capital	-	115.22	115.22	-	-
Retained Earnings	-	107.05	17.79	9.95	9.78
Comprehensive Income & Other	2,915	39.38	2.08	2.08	2.08
Shareholders' Equity	3,338	359.95	233.4	51.77	51.6
Total Liabilities & Equity	5,182	633.41	366.13	99.08	52.29
Total Debt	498.93	132.68	3.12	-	-
Net Cash (Debt)	-485.92	-115.38	57.64	0.84	0.18
Net Cash Growth	-	-	6729.74%	361.20%	-41.52%
Net Cash Per Share	-14.24	-10.40	11.41	0.21	0.05
Filing Date Shares Outstanding	266.66	9.83	9.83	3.97	3.97
Total Common Shares Outstanding	266.66	9.83	9.83	3.97	3.97
Working Capital	833.04	229.61	177.12	51.7	51.4
Book Value Per Share	12.52	36.62	23.74	13.03	12.98
Tangible Book Value	1,306	359.95	233.4	51.77	51.6
Tangible Book Value Per Share	4.90	36.62	23.74	13.03	12.98